5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 17.90▲ | 17.90▲ | 17.90▲ | 17.97▼ | 17.93▼ |
MA10 | 17.86▲ | 17.87▲ | 17.87▲ | 17.85▲ | 17.98▼ |
MA20 | 17.84▲ | 17.84▲ | 17.85▲ | 17.86▲ | 18.37▼ |
MA50 | 17.90▲ | 17.94▲ | 17.99▲ | 18.06▼ | 18.96▼ |
MA100 | 18.10▲ | 18.22▲ | 18.37▲ | 18.46▼ | 19.78▼ |
MA200 | 18.72▼ | 19.21▼ | 19.31▼ | 19.05▼ | 22.10▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.041▲ | 0.047▲ | 0.049▲ | 0.043▲ | -0.007▼ |
RSI | 71.419▲ | 67.286▲ | 66.023▲ | 48.708▼ | 41.884▼ |
STOCH | 38.068 | 37.843 | 38.467 | 58.401 | 22.923 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -65.000 | -80.690▼ |
CCI | 340.278▲ | 354.748▲ | 346.469▲ | 44.418 | -50.268 |
Wednesday, October 01, 2025 08:31 PM
Looking back on therapeutics stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Myriad Genetics (NASDAQ:MYGN) and its peers. Over the next few years, therapeutic ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/10/25 | 18.12 | 18.12 | 17.78 | 17.87 | 3,300 |
13/10/25 | 18.19 | 18.19 | 18.01 | 18.0204 | 6,471 |
10/10/25 | 17.87 | 18.39 | 17.87 | 18.39 | 2,822 |
09/10/25 | 17.82 | 17.8756 | 17.80 | 17.8756 | 2,622 |
08/10/25 | 17.73 | 17.73 | 17.67 | 17.6847 | 1,010 |
07/10/25 | 17.71 | 17.89 | 17.71 | 17.8547 | 1,445 |
06/10/25 | 17.70 | 17.71 | 17.60 | 17.6538 | 1,153 |
03/10/25 | 17.63 | 17.6834 | 17.59 | 17.6834 | 1,560 |
02/10/25 | 17.72 | 17.81 | 17.72 | 17.7206 | 26,897 |
01/10/25 | 17.77 | 17.82 | 17.74 | 17.76 | 8,145 |
|
|
||||
|
|
||||
|
|